Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 68071-2206 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

PDP - 68071 2206 1

PDP - 68071 2206 1

This is a description for a medication called Gabapentin in 800mg doses. It is a prescription medication that has a lot number of 000000 and is also identified by the NDC numbers 68071-2206-1 and 68071-2206-01. The manufacturer's NDC number is 50228-178-01, and the medication comes in a bottle of 100 tablets. The medication has an expiration date of 00-00 and a serial number of 00000000002. It is to be stored at a controlled temperature of 59-86°F and should be kept out of children's reach. If you experience any side effects, call your doctor immediately, and you may also report them to the FDA.*

Figure 1 - image 01

Figure 1 - image 01

This appears to be a chart or table, and without further context, it is not clear what it represents. Therefore, a useful description cannot be generated.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph showing the mean pain scores of individuals over a 4-week fixed dose period with either a placebo or Gabapentin (at doses of 1800 or 2400 mg/day). The x-axis represents the weeks of the study, while the y-axis shows the pain scores. The data appears to indicate that higher doses of Gabapentin correspond to lower mean pain scores.*

Figure 3 - image 03

Figure 3 - image 03

Cockcroft and Gault Equation - image 04

Cockcroft and Gault Equation - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.